JAK1 and ulcerative colitis: Luteolin-7-O-glucoside alleviated dextran sodium sulfate-induced ulcerative colitis mice by decreasing the secretion of inflammatory factors and reducing inflammatory responses via the JAK1-STAT6-SOCS1 pathway [184].